Prescribing information

 

Empower your patients on Entresto by providing them with information about their chronic HFrEF and Entresto. Download the materials below and share them with your patients.

Do not share links to this website or screenshots with patients, as this website is intended for healthcare professionals only.

Patient alert card

Patient alert card

A card for patients to carry with them at all times which contains identity information, as well as important information on contraindications to Entresto treatment, and how to report side effects.
 

Download

Your guide to Entresto

Your guide to Entresto® (sacubitril/valsartan

A guide to help your patients who have been prescribed Entresto know what to expect with treatment. This brochure contains information about what Entresto is, how to take it, what to do if any doses are missed and how to deal with any side effects.
 

Download

HCP/Patient discussion guide

HCP/Patient discussion guide

Interactive PDFs for you and your patient, designed to be used together to facilitate virtual consultations. Download your guide and the corresponding patient guide (to be sent to patients) below.
 

Download HCP guide

Download patient guide

 

Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1

HCP, healthcare professional; HFrEF, heart failure with reduced injection fraction.

Reference

  1. Entresto Summary of Product Characteristics, 2020. 
ENT20-C046(2)c October 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]